Ioanna Triviai

1.2k total citations
23 papers, 531 citations indexed

About

Ioanna Triviai is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Ioanna Triviai has authored 23 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 15 papers in Hematology and 9 papers in Molecular Biology. Recurrent topics in Ioanna Triviai's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (15 papers), Acute Myeloid Leukemia Research (11 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Ioanna Triviai is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (15 papers), Acute Myeloid Leukemia Research (11 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Ioanna Triviai collaborates with scholars based in Germany, Greece and United States. Ioanna Triviai's co-authors include Nicolaus Kröger, Haefaa Alchalby, Christine Wolschke, Anita Badbaran, Thomas Stübig, Boris Fehse, Dominik Wolf‎, Annkristin Heine, Sowmya Parampalli Yajnanarayana and Isabelle Cornez and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Blood.

In The Last Decade

Ioanna Triviai

22 papers receiving 527 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ioanna Triviai Germany 11 296 290 162 130 83 23 531
Thomas Stübig Germany 15 573 1.9× 242 0.8× 268 1.7× 112 0.9× 177 2.1× 25 792
Franck‐Emmanuel Nicolini France 14 397 1.3× 267 0.9× 86 0.5× 137 1.1× 41 0.5× 32 626
Evgeny Klyuchnikov Germany 15 615 2.1× 203 0.7× 183 1.1× 86 0.7× 149 1.8× 57 715
AH Elmaagacli Germany 13 413 1.4× 156 0.5× 90 0.6× 69 0.5× 66 0.8× 15 531
Philippe Agapé France 10 276 0.9× 130 0.4× 88 0.5× 27 0.2× 63 0.8× 20 378
Yoshiko Matsuhashi Japan 12 336 1.1× 115 0.4× 77 0.5× 31 0.2× 117 1.4× 41 521
David Bloxham United Kingdom 11 179 0.6× 156 0.5× 110 0.7× 23 0.2× 73 0.9× 23 452
Keiki Kawakami Japan 11 297 1.0× 107 0.4× 106 0.7× 20 0.2× 125 1.5× 47 488
Andreza Alice Feitosa Ribeiro Brazil 12 251 0.8× 133 0.5× 32 0.2× 39 0.3× 112 1.3× 44 456
Hélène Trebeden‐Negre France 14 165 0.6× 94 0.3× 94 0.6× 63 0.5× 305 3.7× 19 544

Countries citing papers authored by Ioanna Triviai

Since Specialization
Citations

This map shows the geographic impact of Ioanna Triviai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ioanna Triviai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ioanna Triviai more than expected).

Fields of papers citing papers by Ioanna Triviai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ioanna Triviai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ioanna Triviai. The network helps show where Ioanna Triviai may publish in the future.

Co-authorship network of co-authors of Ioanna Triviai

This figure shows the co-authorship network connecting the top 25 collaborators of Ioanna Triviai. A scholar is included among the top collaborators of Ioanna Triviai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ioanna Triviai. Ioanna Triviai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stelzer, Ina A., Kristin Thiele, Ioanna Triviai, et al.. (2021). Vertically transferred maternal immune cells promote neonatal immunity against early life infections. Nature Communications. 12(1). 4706–4706. 50 indexed citations
2.
Koehne, Till, Jan Tuckermann, Ioanna Triviai, et al.. (2021). Osteoblast-specific inactivation of p53 results in locally increased bone formation. PLoS ONE. 16(11). e0249894–e0249894. 3 indexed citations
3.
Gagelmann, Nico, Markus Ditschkowski, Swann Bredin, et al.. (2019). Comprehensive clinical-molecular transplant scoring system for myelofibrosis undergoing stem cell transplantation. Blood. 133(20). 2233–2242. 107 indexed citations
4.
Triviai, Ioanna, Marios Spanakis, T. Scherer, et al.. (2018). ASXL1/EZH2 mutations promote clonal expansion of neoplastic HSC and impair erythropoiesis in PMF. Leukemia. 33(1). 99–109. 15 indexed citations
5.
Christopeit, Maximilian, Gerald Wulf, Eva Wagner, et al.. (2018). Impact of ruxolitinib pretreatment on outcomes after allogeneic stem cell transplantation in patients with myelofibrosis. European Journal Of Haematology. 101(3). 305–317. 34 indexed citations
6.
Wolschke, Christine, Anita Badbaran, Tatjana Zabelina, et al.. (2017). Impact of molecular residual disease post allografting in myelofibrosis patients. Bone Marrow Transplantation. 52(11). 1526–1529. 35 indexed citations
7.
Hermans‐Borgmeyer, Irm, Kerstin Cornils, Boris Fehse, et al.. (2017). High Bone Turnover in Mice Carrying a Pathogenic Notch2 Mutation Causing Hajdu-Cheney Syndrome. Journal of Bone and Mineral Research. 33(1). 70–83. 21 indexed citations
8.
Derlin, Thorsten, Haefaa Alchalby, Peter Bannas, et al.. (2016). Serial 18F-FDG PET for Monitoring Treatment Response After Allogeneic Stem Cell Transplantation for Myelofibrosis. Journal of Nuclear Medicine. 57(10). 1556–1559. 9 indexed citations
9.
Stelzer, Ina A., Ioanna Triviai, María Emilia Solano, & Petra Arck. (2016). Maternal microchimeric CD3+ T cells promote fetal hematopoiesis in fetal bone marrow in mice. Journal of Reproductive Immunology. 115. 81–82. 2 indexed citations
10.
Triviai, Ioanna, Timo Stübig, Birte Niebuhr, et al.. (2015). CD133 marks a stem cell population that drives human primary myelofibrosis. Haematologica. 100(6). 768–779. 13 indexed citations
11.
Hussein, Kais, et al.. (2015). Cytokine Expression Pattern in Bone Marrow Microenvironment after Allogeneic Stem Cell Transplantation in Primary Myelofibrosis. Biology of Blood and Marrow Transplantation. 22(4). 644–650. 9 indexed citations
12.
Derlin, Thorsten, Haefaa Alchalby, Peter Bannas, et al.. (2015). Assessment of bone marrow inflammation in patients with myelofibrosis: an 18F-fluorodeoxyglucose PET/CT study. European Journal of Nuclear Medicine and Molecular Imaging. 42(5). 696–705. 17 indexed citations
13.
Yajnanarayana, Sowmya Parampalli, Thomas Stübig, Isabelle Cornez, et al.. (2015). JAK1/2 inhibition impairs T cell function in vitro and in patients with myeloproliferative neoplasms. British Journal of Haematology. 169(6). 824–833. 120 indexed citations
14.
Triviai, Ioanna, Anita Badbaran, Victoria Panagiota, et al.. (2014). EZH2 Mutations Are Drivers of Clonal Hematopoiesis and Leukemic Transformation in a Mouse Model of Primary Myelofibrosis. Blood. 124(21). 3211–3211. 1 indexed citations
15.
Panagiota, Victoria, Michael Heuser, Michelle Cruz, et al.. (2014). Prognostic Impact of Splicing Factor Mutations in Patients with Myelofibrosis Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. Blood. 124(21). 3171–3171.
16.
Wolschke, Christine, Haefaa Alchalby, Francis Ayuk, et al.. (2013). The Pan- JAK Inhibitor Ruxolitinib Impairs T-Cell Activation, Cytokine Production and Proliferation In Vivo and In Vitro. Blood. 122(21). 2001–2001. 6 indexed citations
17.
Triviai, Ioanna, Birte Niebuhr, Kais Hussein, et al.. (2013). CD133 Marks a Stem Cell Population That Drives Human Primary Myelofibrosis. Blood. 122(21). 1601–1601. 4 indexed citations
18.
Bakopoulou, Athina, Asterios S. Tsiftsoglou, G. Galaktidou, et al.. (2007). Patterns of cell death and cell cycle profiles of cultured WEHI 13 var fibroblasts exposed to eluates of composite resins used for direct and indirect restorations. European Journal Of Oral Sciences. 115(5). 397–407. 8 indexed citations
19.
20.
Bakopoulou, Athina, et al.. (2006). In vitro assessment of cytotoxicity of resin-based dental restorative materials on WEHI 13 var fibroblasts.. PubMed. 19(1). 13–6. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Stübig Breakdown of academic impact, for papers by Franck‐Emmanuel Nicolini Breakdown of academic impact, for papers by Evgeny Klyuchnikov Breakdown of academic impact, for papers by AH Elmaagacli Breakdown of academic impact, for papers by Philippe Agapé Breakdown of academic impact, for papers by Yoshiko Matsuhashi Breakdown of academic impact, for papers by David Bloxham Breakdown of academic impact, for papers by Keiki Kawakami Breakdown of academic impact, for papers by Andreza Alice Feitosa Ribeiro Breakdown of academic impact, for papers by Hélène Trebeden‐Negre
Rankless by CCL
2026